BioLife Solutions, Inc.

NASDAQ:BLFS

Medical - Instruments & Supplies

Healthcare
$38.61 +1.56%

+$0.40 today

Market cap
$1.89B
Beta
1.97
P/E (TTM)
-119.9
EPS (TTM)
-$0.22
52W Low $17.86High $29.62

Volume 4.39M

Average 0.52M

BLFS Income Before Tax

Profit after all operating and non-operating items but before income tax.

BioLife Solutions, Inc.NASDAQ: BLFS

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax turns positive

Q1 FY2026 income before tax was $1.25M, compared with -$434K a year earlier. Trailing-twelve-month income before tax was -$10.4M.

Context

  • Income before tax amounted to 12.6% of revenue in FY2025, down 1.3 pp from a year earlier.
  • Income before tax grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly income before tax holds near $1.25M or moves back toward the trailing-twelve-month quarterly average of -$2.6M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.25M-62.9% QoQ
Last fiscal yearDec 2025
-$12.08M-5.7% YoY
LTMMar 2026
-$10.4M-19.8% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+387.6%——
1 year-5.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(12.08M) USD
Year-over-year change
-5.7%

Income Before Tax vs competitors

How BLFS compares with its peers on the latest reported figures

  • BLFS's LTM Mar 2026 income before tax of -$10.4M is the 3rd highest of the 11 companies compared; the peer median is -$57.26M.
  • Its year-over-year change of -19.8% is the 8th highest of 11, against a peer median of +45.5%.
  • Income before tax amounts to 10.4% of revenue for BLFS, versus a peer median of 12.7%.
BLFS Competitors Peer median
Income Before Tax for BLFS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ATRCAtriCure, Inc.LTM Jun 2026$12.09M +134.3%—2.1%
PHRPhreesia, Inc.LTM Apr 2026-$1.04M +97.4%—0.2%
BLFSBioLife Solutions, Inc.LTM Mar 2026-$10.4M -19.8%—10.4%
HROWHarrow Health, Inc.LTM Mar 2026-$11.17M +48.2%—4.2%
STAASTAAR Surgical CompanyLTM Apr 2026-$19.56M +68.1%—6.7%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026-$46.85M +42.9%—17.7%
NEOGNeogen CorporationLTM Aug 2026-$67.66M +93.7%—7.7%
PLSEPulse Biosciences, Inc.LTM Jun 2026-$80.06M -17.7%—6755.8%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026-$143.68M -69.1%—171.6%
AZTAAzenta, Inc.LTM Sep 2026-$151.01M -3707.5%—24.3%
NVCRNovoCure LimitedLTM Mar 2026-$175.21M -35.0%—26.0%
Peer median (excluding BLFS) -$57.26M+45.5%—12.7%

Competitors are the stored peer set for BLFS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue119.16M76.24M75.86M82.25M96.21M
Cost of Revenue90.31M29.33M96.52M28.58M34.1M
Gross Profit28.85M46.91M46.75M53.67M62.12M
Gross Margin24.2%61.5%61.6%65.3%64.6%
Research & Development11.82M14.8M18.8M7.91M7.57M
Selling, General & Admin48.09M44.93M55.97M50.15M55.37M
Operating Expenses73.34M52.83M117.58M60.8M74.25M
Depreciation & Amortization12.87M19.96M12.3M8.66M4.69M
EBITDA(16.65M)(124.18M)(45.24M)1.53M3.61M
EBITDA Margin-14.0%-162.9%-59.6%1.9%3.7%
Operating Income(35.16M)(5.92M)(23.44M)(7.13M)(1.08M)
Operating Margin-29.5%-7.8%-30.9%-8.7%-1.1%
Interest Income00000
Interest Expense485K687K1.81M719K2.71M
Other Income / Expenses6.13M1.08M4.97M(4.3M)(11M)
Income Before Tax(29.03M)(4.85M)(18.47M)(11.43M)(12.08M)
Pre-Tax Margin-24.4%-6.4%-24.4%-13.9%-12.6%
Income Tax Expense(20.12M)(5.24M)24K(38K)49K
Net Income(8.91M)(139.81M)(66.43M)(20.18M)(12.13M)
Net Margin-7.5%-183.4%-87.6%-24.5%-12.6%
EPS (Basic)(0.23)(3.29)(1.52)(0.44)(0.25)
EPS (Diluted)(0.23)(3.29)(1.52)(0.44)(0.25)
Weighted Avg Shares38.5M42.48M43.72M46.07M47.75M
Weighted Avg Shares (Diluted)38.5M42.48M43.72M46.07M48.65M

BioLife Solutions, Inc.

NASDAQ:BLFS

Intrinsic Alpha fair value

Locked

Current Price

$38.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.